医局（その他）
2020年～
2020年～
| 所属科 | 執筆者名 | 論文名 | 雑誌名 | 年 | 巻 | 号 | ページ |
|---|---|---|---|---|---|---|---|
| 病理診断科 | Tomoyuki Ohuchi12) | Salivary gland polymorphous adenocarcinoma: Clinicopathological features and gene alterations in 36 Japanese patients | J Oral Pathol Med | 2022 | 51 | 8 | 710-720 |
| 消化器内科 | Yoshiyasu Karino | Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study | BMC Gastroenterol | 2021 | 21 | 1 | 489 |
| 消化器内科 | Yoshiyasu Karino | Aging impairs fibrosis-4 index after sustained virologic response by direct-acting antivirals in chronic hepatitis C infection | Ann Hepatol | 2021 | 27 | 1 | doi: 10.1016/j.aohep.2021.100566. |
| 消化器内科 | Yoshiyasu Karino | Factors affecting the recovery of hepatic reserve after sustained virologic response by direct-acting antiviral agents in chronic hepatitis C virus-infected patients | J Gastroenterol Hepatol | 2021 | 36 | 2 | 367-375 |
| 病理診断科 | Tomoyuki Ohuchi | Salivary duct carcinoma with rhabdoid features-No or aberrant expression of E-cadherin and genetic changes in CDH1 Immunohistochemical and genetic analyses of 17 cases | Am J Surg Pathol | 2021 | 45 | 4 | 469-449 |
| 病理診断科 | Tomoyuki Ohuchi | Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma | Pathol Int | 2021 | 71 | 2 | 113-123 |
| 病理診断科 | Tomoyuki Ohuchi | A rare case of Helicobacter pylori-uninfected intramucosal poorly differentiated adenocarcinoma that occurred in the gastric fornix | Clin J Gastroenterol | 2020 | Online | ||
| 腫瘍内科 | Hiroyuki Okuda | Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G) | Target Oncol | 2020 | 15 | 5 | 623-633 |
| 腫瘍内科 | Hiroyuki Okuda | Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G) | Eur J Cancer | 2020 | 135 | 11-21 | |
| 腫瘍内科 | Hiroyuki Okuda | An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect) | J Anus Rectum Colon | 2020 | 4 | 2 | 79-84 |
| 腫瘍内科 | Hiroyuki Okuda | A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial) | Clin Colorectal Cancer | 2020 | 19 | 1 | 13-21 |
雑誌掲載論文一覧 2009年~2019年
雑誌掲載論文一覧 2009年~2019年
| 所属科 | 執筆者名 | 論文名 | 雑誌名 | 年 | 巻 | 号 | ページ |
|---|---|---|---|---|---|---|---|
| 泌尿器科 | 谷口明久 | 精巣漿膜を用いて代用膀胱直腸瘻閉鎖術を施行した1例 | 泌尿器外科 | 2019 | 32 | 6 | 869-871 |
| 腫瘍内科 | Hiroyuki Okuda | First-line chemotherapy with S-1 alone or S-1plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study | Gastric Cancer | 2018 | 21 | 5 | 792-801 |
| 腫瘍内科 | Hiroyuki Okuda | First-line chemotherapy with S-1 alone or S-1plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study | Gastric Cancer | 2018 | 21 | 5 | 492-801 |
| 腫瘍内科 | Hiroyuki Okuda | Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase Ⅱ trial and biomarker study(WJOG7212G) | Gastric Cancer | 2018 | 21 | 1 | 84-95 |
| 腫瘍内科 | Hiroyuki Okuda | Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastiric cancer: a phaseⅡ trial and biomarker study (WJOG7212G) | Gastric Cancer | 2017 | Online公開 | ||
| 腫瘍内科 | Hiroyuki Okuda | EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics | Oncotarget | 2017 | 8 | 11 | 17810-17818 |
| 腫瘍内科 | 川上賢太郎 | 食道癌ー化学放射線療法 | 臨牀と研究 | 2017 | 94 | 12 | 1-6 |
| 腫瘍内科 | Hiroyuki Okuda | Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G | Cancer Sci | 2016 | 107 | 12 | 1843-1850 |
| 病理診断科 | 大内知之 | 唾液腺導管癌のup to date -病理組織学的事項を中心に- | 日本唾液腺学会誌 | 2016 | 57 | 63-72 | |
| 泌尿器科 | 平川和志 | 民間病院におけるダ・ヴィンチ導入の有用性と課題 | 新医療 | 2013 | 40 | 3 | 124-127 |
| 泌尿器科 | 小林智治 | 尿路系に発生した続発生悪性リンパ腫の2症例 | 泌尿器外科 | 2015 | 28 | 7 | 1247-1251 |
| 病理診断科 | 大内知之 | 顎骨検体の取り扱い方 －切り出し、脱灰など－ | 病理と臨床 | 2013 | 31 | 5 | 486-491 |
| 麻酔科 | 小村好弘 | 片肺換気において麻酔薬がPaO2に与える影響-プロポフォールとイソフルランの比較 | 日本臨床麻酔学会誌 | 2000 | 20 | 97-100 |
